Medicare Enrolled
Dr. Nutan Bhaskar, MD
Pulmonary Disease · Glendora, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhaskar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhaskar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhaskar
Dr. Nutan Bhaskar is a pulmonary disease specialist in Glendora, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Bhaskar performed 3,469 Medicare services across 2,054 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhaskar received a total of $4,782 from 31 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhaskar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 9% volume in CA
$4,782 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,469
Medicare services
Top 9% in CA for pulmonary disease
2,054
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
690 | $98 | $191 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
688 | $65 | $147 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
685 | $171 | $380 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $78 | $194 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
246 | $16 | $117 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
226 | $33 | $185 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
220 | $25 | $154 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
147 | $143 | $284 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
30 | $37 | $582 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
29 | $16 | $30 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
20 | $15 | $38 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
16 | $70 | $373 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $143 | $297 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
15 | $119 | $231 |
| Spirometry test A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function. |
15 | $20 | $39 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
15 | $35 | $71 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
15 | $13 | $34 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
15 | $50 | $95 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
15 | $28 | $47 |
| Hemoglobin measurement A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
13 | $5 | $9 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
13 | $29 | $57 |
| New patient office visit, complex (60-74 min) | 13 | $157 | $357 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
13 | $20 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
11 | $6 | $6 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,782
Total received (2018-2024)
Avg $683/year across 7 years
Top 28% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,532 (94.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$250 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$218
2023
$632
2022
$817
2021
$748
2020
$479
2019
$59
2018
$1,829
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$71
Shionogi Inc
$34
Regeneron Healthcare Solutions, Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
AstraZeneca Pharmaceuticals LP
$23
Insmed, Inc.
$22
ANI Pharmaceuticals, Inc.
$20
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,472
Boehringer Ingelheim Pharmaceuticals, Inc.
$567
AstraZeneca Pharmaceuticals LP
$505
Genentech USA, Inc.
$245
Takeda Pharmaceuticals U.S.A., Inc.
$204
Mallinckrodt Hospital Products Inc.
$193
Mallinckrodt LLC
$160
United Therapeutics Corporation
$143
Mylan Specialty L.P.
$125
Bayer HealthCare Pharmaceuticals Inc.
$117
Actelion Pharmaceuticals US, Inc.
$108
Regeneron Healthcare Solutions, Inc.
$97
Grifols USA, LLC
$95
Novartis Pharmaceuticals Corporation
$94
Shire North American Group Inc
$88
Sunovion Pharmaceuticals Inc.
$68
Electromed, Inc.
$58
GENZYME CORPORATION
$47
Advanced Respiratory, Inc
$47
ANI Pharmaceuticals, Inc.
$44
Philips Electronics North America Corporation
$44
Insmed, Inc.
$39
Exeltis, USA Inc.
$34
Shionogi Inc
$34
CSL Behring
$34
E.R. Squibb & Sons, L.L.C.
$25
Astellas Pharma US Inc
$22
Mallinckrodt Enterprises LLC
$22
Inogen, Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$18
PFIZER INC.
$11
Top 3 companies account for 53.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · AMBISOME · ANORO · ANORO ELLIPTA · Adempas · Arikayce · BREO · BREZTRI · CHANTIX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Fetroja · GLASSIA · InogenOne · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Utibron · WATCHMAN · Wellcentive Undiv · XOLAIR · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
101
Per 100K population
1.0
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhaskar is a mixed practice specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhaskar experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bhaskar performed 690 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhaskar receive payments from pharmaceutical companies?
Yes. Dr. Bhaskar received a total of $4,782 from 31 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhaskar's costs compare to other pulmonary diseases in Glendora?
Dr. Bhaskar's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhaskar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Glendora
Browse pulmonary diseases in Glendora ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology